These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19209043)

  • 41. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Migraine Nurses in Primary Care: Costs and Benefits.
    van den Berg JSP; Steiner TJ; Veenstra PJL; Kollen BJ
    Headache; 2017 Sep; 57(8):1252-1260. PubMed ID: 28524254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Loder EW; Gorman JA; Stewart WF; Reed ML; Fanning KM; Serrano D; Lipton RB
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An examination of productivity and resource utilization associated with epoetin alfa treatment in employees with predialysis chronic kidney disease.
    Papatheofanis F; Bookhart BK; Muser E; Piech CT
    J Occup Environ Med; 2008 May; 50(5):584-9. PubMed ID: 18469628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
    Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
    Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal change in migraine headache-days and indirect cost consequences.
    Stewart WF; Wood GC; Bruce C; Buse DC; Runken MC; Lipton RB
    J Occup Environ Med; 2011 May; 53(5):478-87. PubMed ID: 21508870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
    Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF
    Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic burden and costs of chronic migraine.
    Lanteri-Minet M
    Curr Pain Headache Rep; 2014 Jan; 18(1):385. PubMed ID: 24338699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Healthcare resource use and indirect costs associated with migraine in Italy: results from the
    Martelletti P; Schwedt TJ; Vo P; Ritrovato D; Reilly MC; Naclerio M; Ranjan P; Kleebach J; Joshi P
    J Med Econ; 2021; 24(1):717-726. PubMed ID: 33955821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Promoting health and productivity for depressed patients in the workplace.
    Sullivan S
    J Manag Care Pharm; 2005 Apr; 11(3 Suppl):S12-5. PubMed ID: 15804203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees.
    Sakai F; Igarashi H; Yokoyama M; Begasse de Dhaem O; Kato H; Azuma Y; Koh R; Phillips H; Singh N; Craven A; Dodick DW; Miyake H
    Cephalalgia; 2023 Apr; 43(4):3331024231165682. PubMed ID: 36967710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the impact of migraine onset on work productivity.
    Landy SH; Runken MC; Bell CF; Higbie RL; Haskins LS
    J Occup Environ Med; 2011 Jan; 53(1):74-81. PubMed ID: 21187794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct cost burden among insured US employees with migraine.
    Hawkins K; Wang S; Rupnow M
    Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC; Manack AN; Fanning KM; Serrano D; Reed ML; Turkel CC; Lipton RB
    Headache; 2012; 52(10):1456-70. PubMed ID: 22830411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of a health promotion program on employee health risks and work productivity.
    Mills PR; Kessler RC; Cooper J; Sullivan S
    Am J Health Promot; 2007; 22(1):45-53. PubMed ID: 17894263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of a headache program in the workplace. The effect of education.
    Schneider WJ; Furth PA; Blalock TH; Sherrill TA
    J Occup Environ Med; 1999 Mar; 41(3):202-9. PubMed ID: 10091144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.